Biotech: Cancer Beats AstraZeneca

Having trouble reading this e-mail? Click here for mobile version.

FORBES.COM BIOTECH NEWSLETTER OCTOBER 28, 2009
Cancer Beats AstraZeneca Robert Langreth Company pulls application for a promising experimental drug. Hefty Side Effect For Kids On Antipsychotics Robert Langreth Study finds troubling weight gains in children taking brand-name psychiatric drugs. Reviving Tysabri Matthew Herper The drug's inventor believes a new test might identify people who are less at risk for a deadly side effect. Swine Flu Shot Gets Mexican Test Matthew Herper A vaccine for the 2009 H1N1 influenza virus made in insect cells could be approved in Mexico as early as next year.	ADVERTISEMENT
Forbes Magazine Special Offer! Forbes.com Newsletter readers receive a Free Trial Issue of Forbes... no risk... no obligation! If you decide to subscribe to Forbes, you can do so at special introductory savings, and get 25 more issues - 26 in all - for just $1.15 a copy. You save 77% off the $4.99 newsstand price. If you decide Forbes is not for you, simply write cancel on the invoice you receive and return it. The FREE issue is yours to keep with our compliments. Sign up Today for your Free Trial Issue! © 2009 Forbes.com LLC.™